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Introduction
Since the 20th century the Bacille Calmette-Guérin (BCG) vaccine 
there is only one defensive tool against Mycobacterium tuberculosis 
(MTB) introduced as a shot of a 90-year-old vaccine (attenuated 
virulence of Mycobacterium bovis). BCG limits the growth and 
protect against MTB and aids in clearance of bacillary loads during 
chemotherapeutic treatment in the active post-infective stage [1]. BCG 
vaccination can have obvious public health advantages. It can lessen 
the burden of TB-related disorders such as LTBI prevalence and active 
TB incidence in children [2]. TB incidence rose again after abandoning 
routine BCG in the mid-1980s even with the introduction of other 
preventive measures [3]. But the efficacy impacts of BCG vaccination 
whether confers lifelong immunity or adversely causing tuberculosis 
(TB) through indirectly forming latent tuberculosis infection (LTBI) 
is still unclear. Worldwide the tuberculin skin test (TST) has been 
the standard diagnostic test for detection of LTBI for more than 100 
years. It was first described by Robert Koch in 1890, and involves 
injecting intradermally a purified protein derivative (PPD) of 0.1 ml 
tuberculin (which is a glycerol extract of the bacillus) followed by 
measurement of the localized delayed-type hypersensitivity (DTH-IV) 
reaction [4]. The TST has several limitations and cannot distinguish 
between previous BCG vaccination and current TB infection due to 
poor specificity in BCG negative people and poor sensitivity in BCG-
vaccinated individuals. Meta-analysis has shown that previous BCG 
administration increases the likelihood of TST false-positive results up 
to 15 years after-vaccination [5].
BCG vaccination might alter the interpretation of a positive PPD, 
and therefore TST interpretation is extremely limited as a diagnostic tool 
to prove whether a positive result is caused by MTB infection or cross-
reactivity resulting from BCG vaccination (containing live attenuated 
M. bovis antigens), and has to be interpreted taking into consideration 
both the pre-test risk of TB infection and BCG vaccination status.
Objective
To assess the interference effect of BCG vaccination on the results 
of the tuberculin skin test.
Sub-objective
Assess with evidence-based the cross-reactive effects of BCG 
vaccine on Mantoux test (used for LTBI diagnosis) according to a 
new defined categories of latent TB infection using four TB diagnostic 
testing implemented on healthy new immigrants.
Materials and Methods
The study design was a cross-sectional study involving a sample 
of 180 new immigrants to Kuwait during four months (between 
February and May) 2010 during their compulsory registration at Al 
Farwaniya Immigration Centre (the most populous region in Kuwait 
covering 907,321 out of the 3,442,945 total residential population). 
Included participants were randomly chosen as one in every thirty four 
expatriates without selection bias.
The study screening tools were a structured questionnaire to 
assess the socio-economic characteristics and past history of BCG 
vaccination with careful examination for the presence of characteristic 
BCG scar on both arms. Four tests were performed on each immigrant 
simultaneously. Two blood samples for both IGRAs (three 1 ml tubes 
for QuantiFERON Gold In-Tube and one 8ml tube for T-SPOT.TB 
test) were taken. Thirdly, this was followed by performing TST through 
intradermal administration of five tuberculin units (5TU) of 0.1 ml 
of purified protein derivative (PPD) (Tubersol: Sanofi Pasteur Ltd, 
Toronto, Ontario, Canada), using 1 ml disposable tuberculin syringes, 
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Abstract
The Bacelle Calmette-Guérin (BCG) vaccine has existed for 90 years and is the most widely used of all current 
national childhood immunization programmes. The impact of BCG vaccination on transmission of Mycobacterium 
tuberculosis is not clear or whether BCG confers lifelong immunity through sufficient protection against formation 
and diagnosis of latent tuberculosis infection (LTBI) is recently questionable especially in tuberculosis endemic 
regions and vaccinated high risk individuals, which was discussed along the paper work following a new evidence-
based criteria for LTBI diagnosis.
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on the volar surface of the mid-anterior left forearm. The TST result 
was read as firm and well circumscribed indurations or soft ill-defined 
swelling/margins using a small flexible caliper (a 10-15 cm length 
ruler calibrated in mm). Adverse skin reactions such as erythematous 
skin reactions or hematomas or vesicles were also investigated. A 
TST reaction of transverse diameters of the palpable hardened skin 
areas more than or equal 10 mm (>10 mm) was considered positive, 
in accordance with The American Thoracic Society and Centers for 
Disease Control and Prevention guidelines and Ministry of Health in 
Kuwait [6]. Fourthly, a chest X-ray was performed. All healthy adults 
aged between 18 and 60 years were randomly enrolled and TST reaction 
results interpreted within 48 hours and 72 hours. Immigrants with a 
history of previous TST less than six months prior to enrollment and/
or at increased risk of adverse reactions(s) to TST such as venipuncture 
or skin allergy and/or having acute infectious disease within the last six 
months were excluded. Participants came after 5 days and/or missed 
follow-up results were also excluded.
Table 1 presents a new laboratory classification of diagnostic testing, 
which can be considered as new criteria for LTBI case definition.
Statistical analysis
Lowest accepted sample size calculated by the Confidence Interval 
Analysis Software was 167 out of average annual 80,000 expatriates 
(theoretically are healthy or free-of-disease) entering to Kuwait [7]. 
Data were analyzed using the Statistical Package for Social Sciences 
software, version 17.0 [8]. Categorical variables were analyzed using 
a Likelihood ratio (LLR χ2(d.f.)) test when Pearson’s chi square was 
inappropriate for small sample (measured by SPSS as expected values 
were more than 20% or more 5 categories of total table categories). 
Similar to LLR χ2use, non-normally distributed continuous variables 
(age of BCG vaccination in years) were analyzed using a Kruskal-
Wallis (KW χ2(d.f.) test and a p-value of less than 0.05 was considered 
as the level of statistical significance. Data limits using the mid-spread 
(middle 50%) represented by the interquartile range (IQR) and 
semi-interquartile range (SIQR) as half the interquartile range [9]. 
Questionnaire quantitative variables were drawn as box-and-whiskers 
plots diagrams using SPSS version 17.0 [8].
Results
Socio-demographic characteristics
The overall median age of the immigrants was 31.5 years, with an 
interquartile range (IQR) of 11 years and the semi-interquartile range 
(SIQR) of 5.5 year (KW χ2(4)=25.741, p<0.001). Statistically significant 
differences were detected between nationality and LTBI case categories. 
Most of the immigrants in this study 77.22% (139/180) came from 
counties in which TB was endemic: Indians 35%, Filipinos 19.44%, 
Nepalis 15%, Ethiopians 7.78% and Sri Lankans 3.3%. Egyptians 
represented the majority of immigrants coming from non-endemic 
countries: 14.44% (26/180) (LLR χ2(52)=72.522, p=0.032).
Tuberculin skin test
Mantoux (induration) reaction was measured in 98.33% (177/180) 
who fulfilled the inclusion criteria for TST results. The TST results of 
three excluded immigrants were as follows: two participants came on 
day 7 (a male Indian electrician and a female Nepali housemaid) and 
one participant did not return for a TST reading (a female Ethiopian 
housemaid). The frequency of LTBI reactions in the new immigrants, 
including the three missed follow-up participants, is shown in Table 2.
According to the induration reaction, the prevalence of LTBI in 
the sample of new immigrants was zero (0/177) using the TST method. 
Applying the new classification criteria of LTBI, all participants 
belonged to the normal results within score I (zero=negative reaction) 
and score II (≤ 5 mm induration) in 97.78% (176/180). Immigrants 
had score III (= 5 - <10 mm induration) were 0.56% (1/180) with no 
observed case for positive abnormal reaction above the modified ‘cut-
off ’ value (>10 mm) (LLR χ2(8)=33.865, p<0.001) as shown in the next 
Table 3.
Average LTBI category is zero (means no detected cases), 
Missed=excluded case due to missed follow-up or came after 5 days 
for reading of TST reaction, cannot be judged means excluded cases 
(3 missed follow-up for TST results and one pregnant female not 
preformed chest X-ray due to contraindication)
BCG vaccination status
Analysis of the influence of BCG vaccination status on test results 
Tuberculosis diagnostic test results’ LTBI case
Old (Standard) New Test score
definition
CXR TST QFT-GIT T-SPOT .TB
- - - - 1 Negligible
+ - - - 2 Low
- + - - 3 Low
- - + - 4 Low
- - - + 5 Low
+ + - - 6 Average
+ - + - 7 High
- + + - 8 High
+ - - + 9 High
- + - + 10 High
- - + + 11 Extremely High
+ - + + 12 Extremely High
- + + + 13 Extremely High
+ + + + 14 Extremely High
CXR=chest X-ray, TST=tuberculin skin test, IGRAs=interferon gamma release 
assays, QFT-GIT=QuantiFERON Gold In-Tube test, T-SPOT .TB=T-SPOT .TB 
test, LTBI=latent tuberculosis infection
*Risk defined according to Thrusfield, M. (2007): Negligible (of 
likelihood)=Insignificant, Low=less than average, Average=usual amount of risk, 
High=above the normal or average level, Extremely high=outermost higher than 
average
Table 1: New classification representing categorization criteria for diagnosis 
of latent tuberculosis infection cases using a combination of four-tuberculosis 
diagnostic tests and score for latent tuberculosis infection case diagnosis.
Mantoux Score grade LTBI diagnosis Final result n (%)
response (mm)
0 I Negative(no reaction) Normal 170 (96.04%)
1 - < 5 II Normal (reactive) Normal 6 (3.38%)
5 - < 10 III Borderline Normal 1 (0.05%)
10 - < 15 IV Positive Abnormal 0 (0.00%)
15 - < 20 V Highly positive Abnormal 0 (0.00%)
> 20 VI Definite Abnormal 0 (0.00%)
Excluded - Cannot be judged - 3 (1.66%)
Modified ‘cut-off’ point value of TST induration was more than 10 mm, score (-)=no 
score for excluded case (due to missed follow-up or result reading after 5days), 
mm=millimetre induration
Table 2: Skin test response and score frequency of latent tuberculosis infection of 
the 180 new immigrants to Kuwait, February-May, 2010.
Citation: Harbie AA, Picozzi K, Thrusfield M, Sadek A, Welburn SC (2012) Is Bacille Calmette-Guérin (BCG) Vaccine a Known Risk Factor for Latent 
Tuberculosis Infection?: A Cross-sectional Study on 180 New Immigrants from BCG-vaccinated Countries to Kuwait. J Vaccines Vaccin 
3:150. doi:10.4172/2157-7560.1000151
Page 3 of 5
Volume 3 • Issue 6 • 1000151
J Vaccines Vaccin
ISSN:2157-7560 JVV an open access journal
is shown in Table 3. BCG vaccination status was ascertained from the 
participants through availability of reliable past history of vaccination 
and/or presence of a characteristic BCG scar. Analysis of the effects 
of BCG vaccination status (either vaccinated or non-vaccinated) 
represented in relation to the defined cases of latent tuberculosis 
infection categories is shown in Table 4.
The overall median age of BCG vaccination for the 180 participants 
was 5 years (IQR=2 years). The ‘high’ LTBI group had been vaccinated at 
older ages (median=7.5 years, IQR=6 years). The minimum (youngest) 
age of vaccination was one year versus the oldest maximum age of 13 
years was answered (Table 4). However these findings did not show a 
statistically significant difference between normal vaccination ages for 
LTBI development (KW χ2(4)=3.330, p=0.504) (Figure 1).
Presence of BCG vaccination scar was not a statistically significant 
risk factor for LTBI development or to cause positive a TST reaction, 
even in those expatriates classified as ’high’ and ’extremely high’ LTBI 
cases who were having forearm scar.
A positive scar was detected in 86.11% (155/180) of participants 
(LLR χ2(4)=6.104, p=0.192). The overall median age of BCG vaccination 
for the participants was 5 years (IQR=2 years) (Table 4).
Immigrants having a history of exposure to poultry animals e.g. 
Negligible Low Average High Extremely High
Can
not be judged Total
Tuberculin Skin Test (n=90) (n=36) (n=0) (n=4) (n=46) (n=180) Likelihood p-value
n % n % n % n % n % n % n %
Score I (<5) 90 100.00 36 100.00 0 0.00 3 75.00 46 100.00 1 25.00 176 97.78
TST Score Score II (5-9) 0 0.00 0 0.00 0 0.00 1 25.00 0 0.00 0 0.00 1 0.56
L L R 
χ2(8)= <0.001
Missed 0 0.00 0 0.00 0 0.00 0 0.00 0 0.00 3 75.00 3 1.67 33.865
0 (Negative-
85 94.44 36 100.00 0 0.00 3 75.00 45 97.83 1 25.00 170 94.44No reaction)
TST <5 (Reactive-
5 5.56 0 0.00 0 0.00 0 0.00 1 2.17 0 0.00 6 3.33
2
cutaneous in Normal)
<0.001duration  size 37.947
(mm) 5-9 (Reactive-
0 0.00 0 0.00 0 0.00 1 25.00 0 0.00 0 0.00 1 0.56Borderline)
Missed 0 0.00 0 0.00 0 0.00 0 0.00 0 0.00 3 75.00 3 1.67
TST   adverse 
reaction No 90 100.00 36 100.00 0 0.00 4 100.00 46 100.00 1 25.00 177 98.33
L L R 
χ2(4)= <0.001
Missed 0 0.00 0 0.00 0 0.00 0 0.00 0 0.00 3 75.00 3 1.67 26.017
Average LTBI category is zero (means no detected cases), Missed=excluded case due to missed follow-up or came after 5 days for reading of TST reaction, cannot be 
judged means excluded cases (3 missed follow-up for TST results and one pregnant female not preformed chest X-ray due to contraindication)
Table 3: Distribution of tuberculin skin test results according to latent tuberculosis infection categories  of 180 new immigrants to Kuwait, February-May, 2010.
Negligible Low Average High Extremely High
Can
not be judged Total
BCG  vaccination 
against Likelihood
p-valueTB (n=90) (n=36) (n=0) (n=4) (n=46) (n=4) (n=180) ratio
n % n % n % n % n % n % n %
History of 
vaccination
Yes 78 87 28 77.78 0 0 4 100.00 41 89 3 75.00 154 85.56
No 10 11 7 19.44 0 0 0 0.00 5 11 1 25.00 23 12.78
L L R 
χ2(8)= 0.706
Unknown 2 2 1 2.78 0 0 0 0.00 0 0 0 0.00 3 1.67 5.470
Age  of 
B C G 
vaccination
Median
5.00 (2) 6.00 (3) - - 7.50 (6) 5.00 (2) 4.00 (-) 5 (2)
KW χ2(4)=
0.504
(IQR) 3.330(years)
Presence of Positive 79 87.78 27 75.00 0 0 4 100.00 41 89.13 4 100.00 155 86.11
L L R 
χ2(4)= 0.192
BCG scar
Negative 11 12.22 9 25.00 0 0 0 0.00 5 10.87 0 0.00 25 13.89 6.104
Animal
exposure in
country
Yes 51 56.67 18 50 0 0 1 25.00 24 52.17 0 0.00 94 52.22
L L R 
χ2(4)= 0.094
No 39 43.33 18 50 0 0 3 75.00 22 47.83 4 100.00 86 47.78
Having
cow?
Yes 16 17.78 5 14 0 0 0 0.00 7 15.22 0 0.00 28 15.56 LLR χ2(4)=
No 74 82.22 31 86 0 0 4 100.00 39 84.78 4 100.00 152 84.44 3.114
Table 4: Distribution of Bacillus Calmette-Guérin (BCG) vaccination status against tuberculosis according to latent tuberculosis infection categories of 180 new immigrants 
to Kuwait, February-May, 2010.
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hen, duck and/or dairy animals e.g. goat, buffalo and/or dog in their 
mother country were 52.22% (94/180), and had no significant statistical 
association with LTBI suspicion except at the 10% level of significance 
according to the LTBI categories. Table 4 shows the distribution of 
the majority for those considered as ’negligible’ LTBI cases in 56.67% 
(51/90) and ’extremely high’ LTBI individuals in 52.17% (24/46) (LLR 
χ2(4)=7.928, p=0.094). On the other hand, a correlation between 
owning and/or exposure to cattle (cow) in mother countries and LTBI 
development was detected only in 15.56% (28/180) of total immigrant 
cases, but was not statistically significant (LLR χ2(4)=3.114, p=0.539) 
(Table 4).
Discussion
The influx of BCG-vaccinated immigrants in non-endemic countries 
from TB high-incidence regions represents a potential pool for new TB 
infection and highlights the need for LTBI early and accurate detection 
(reducing TB reservoirs) by using other higher specific diagnostics 
such as interferon gamma release assays (IGRAs) [10]. A common 
confounder, which affects TST reactivity, is prior vaccination with BCG 
vaccine, and/or the strain and dose of BCG used, and/or method of 
vaccine administration and age at vaccination. Successful vaccination 
can be assessed by the presence or absence of a BCG scar [11]. Similar 
finding was emphasized on skin testing in BCG-vaccinated populations 
to predict LTBI suspicious carriers [12]. Therefore TB skins testing 
at immigrant entry centres in Kuwait that serve large foreign-born 
populations can be effective and might add suspicion for LTBI carriers. 
Li et al. (2010) [13] detected LTBI prevalence of positive TST in 24.4% 
(higher among foreigners) in BCG-vaccinated which help to target TST 
testing before starting immigrant’s chemoprophylaxis.
Exposure to previous BCG vaccination did not significantly reduce 
the risk of being diagnosed as active or latent TB was also revealed by 
Caley et al. (2010) [14], in common with our findings.
This study proved that the presence of a BCG scar and related TST 
negative results of all immigrants were not significantly associated with 
a higher prevalence of LTBI as also noted by Demkow et al. (2008) 
[15]. Other similar significant findings was detected the absence of risk 
difference in TB patient contacts having positive BCG scar compared 
to other normal control contacts without scars [16]. Also Kik et al. 
(2009) [17] showed no association between the presence of BCG scar 
with recent exposure to TB in immigrants having positive IGRAs and 
TST results.
Since BCG-TST positive reactivity wanes with time (if more than 
five years have elapsed since administration of BCG vaccine) - a positive 
TST reaction is most likely a result of exposure to MTB infection [18]. 
Gomes and colleagues (2011) [19] have recently concluded that waning 
of the BCG-induced protection was associated with raised risks of TB 
morbid rates in children aged between three and five years. Soysal et 
al. concluded that absence of an immunization scar can determine 
the likelihood for TB infection and is significantly associated with TB 
disease severity, which can be related to the level of exposure to MTB [2].
TST reactions can be interpreted regardless of BCG vaccination 
history [6]. Absence of positive TST reactions in our study strengthens 
the inference that BCG is not interfering with TST interpretation even 
though 86.11% (155/180) of participants had already been vaccinated 
against TB with BCG around pre-school ages. Similar related finding we 
rerecorded by Minodier et al. (2010) [20], namely that a positive TST is 
more likely to be related to an increased duration of TB exposure in the 
TB-endemic country of birth rather than to previous BCG vaccination. 
TST cannot be positive in certain biological factors due to suppression 
of DTH-IV reaction and T-lymphocytes such as malignancies and viral 
infections (e.g. HIV) [21].
Bradshaw et al. (2011) [22] suggested that advancing age increases 
the likelihood of exposure to unpasteurized dairy products and cross-
reactions of environmental mycobacterial antigens using IGRA tests. 
A similar significance in our research results of those participants 
having past history of exposures to various animals and positive BCG 
scar without LTBI diagnosis. On the contrary Grafein et al. (2011) [23] 
concluded that there was an absence of a significant association between 
the presence of LTBI and a BCG scar, but presence of a significant 
association with consumption of unpasteurized (cows) milk in the past 
6 months, which can be related to Mycobacterium bovis.
Similar to the majority of BCG-related publications, the size of 
BCG scar was not measured in our research because did not correlate 
with protection against TB, and also is not an indication for diagnosis 
(or presence) of LTBI. A similar result was also achieved by Crampin 
et al. (2009) [24].
TST reactivity caused by BCG vaccine generally wanes with the 
passage of time, but periodic skin testing may prolong reactivity in 
vaccinated persons, the phenomenon of ‘boosting reactivity‘ [6] (CDC, 
2010). On the contrary, TST reaction size and TST results were not 
affected by the time since the last dose of BCG vaccination, the number 
of BCG scars or BCG vaccination schedule in children, and significantly 
affected the decision for LTBI prophylaxis [25].
Study Limitation and Strength
The absence of a gold standard test for latent TB infection and TB 
can be considered as a limiting factor. Another limitation is the small 
sample size which might constrain generalization of the results to a 
larger population and wider community. On the other hand presenting 
and comparatively testing the new evidence-based diagnostic criteria 
for LTBI in addition to absence of any previous data on LTBI prevalence 
in immigrants or Kuwait residents add strength for future comparison.
12.5
10
7.5
5
2.5
0
Negligible
LTBI case categories
Low High Extremely high Cannot be judged
A
ge
 o
f B
C
G
 v
ac
ci
na
tio
n 
(y
ea
rs
)
Figure1: Box-and-whisker plots of distribution of BCG vaccination age (years) 
according to the defined case categories of latent tuberculosis infection for 
180 new immigrants to Kuwait during February and May, 2010 *Outlier values, 
xMaximum and minimum outlier values.
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Conclusions
Tuberculin skin test is extremely limited as a diagnostic tool for 
latent tuberculosis infection to prove whether a positive result is caused 
by cross-reactivity resulting from BCG vaccination. Still a history of 
BCG and/or presence of vaccination scar (those answered ‘No’ or 
‘Unknown’ vaccination status) is not a contraindication for tuberculin 
skin testing or LTBI chemoprophylaxis in suspected individuals.
Recommendations
The relationship between immunogenicity against tuberculin skin test in the 
response to BCG vaccination needs to be elucidated. Considering the confounding 
effect of Mycobacterium tuberculosis risk factors, BCG efficacy and protection need 
further evaluation using interferon gamma release assays to compare between 
LTBI detected in both vaccinated and non-vaccinated populations. Emphasis on 
skin testing in BCG-vaccinated populations should be considered in the appropriate 
clinical setting to predict LTBI suspicious carriers.
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